Acetyl-cinobufagin suppresses triple-negative breast cancer progression by inhibiting the STAT3 pathway

Background: The incidence of breast cancer (BC) worldwide has increased substantially in recent years. Epithelial-mesenchymal transition (EMT) refers to a crucial event impacting tumor heterogeneity. Although cinobufagin acts as an effective anticancer agent, the clinical use of cinobufagin is limit...

Descripción completa

Detalles Bibliográficos
Autores principales: Qi, Yufeng, Wu, Haodong, Zhu, Tianru, Liu, Zitian, Liu, Conghui, Yan, Congzhi, Wu, Zhixuan, Xu, Yiying, Bai, Ying, Yang, Lehe, Cheng, Dezhi, Zhang, Xiaohua, Zhao, Haiyang, Zhao, Chengguang, Dai, Xuanxuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2023
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10497018/
https://www.ncbi.nlm.nih.gov/pubmed/37651362
http://dx.doi.org/10.18632/aging.204967

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10497018/
https://www.ncbi.nlm.nih.gov/pubmed/37651362
http://dx.doi.org/10.18632/aging.204967

Ejemplares similares